Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis
- 1 August 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (2) , 653-663
- https://doi.org/10.1046/j.1523-1755.2001.060002653.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Furosemide stimulates macula densa cyclooxygenase-2 expression in ratsKidney International, 2001
- COX-2 inhibitorsThe Lancet, 1999
- Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamideAmerican Journal of Kidney Diseases, 1998
- Bindarit retards renal disease and prolongs survival in murine lupus autoimmune diseaseKidney International, 1998
- Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitorBritish Journal of Pharmacology, 1997
- Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritisKidney International, 1995
- THROMBOXANE AUGMENTATION OF ALLOREACTIVE T CELL FUNCTIONTransplantation, 1992
- Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus NephritisNew England Journal of Medicine, 1989
- Increased renal thromboxane production in murine lupus nephritis.Journal of Clinical Investigation, 1986
- Therapeutic studies in NZB/W MICEArthritis & Rheumatism, 1975